Cargando…
Soluble E-Cadherin: An Early Marker of Severity in Acute Pancreatitis
Background/Aims. At present, there is no simple test for predicting severity in acute pancreatitis. We investigated the use of an assay of soluble E-cadherin (sE-cadherin). Methods. Concentrations of sE-cadherin, from 19 patients with mild acute pancreatitis, 7 patients with severe acute pancreatiti...
Autores principales: | Sewpaul, A., French, J. J., Khoo, T. K., Kernohan, M., Kirby, J. A., Charnley, R. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674558/ https://www.ncbi.nlm.nih.gov/pubmed/19421334 http://dx.doi.org/10.1155/2009/397375 |
Ejemplares similares
-
T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy?
por: French, J J, et al.
Publicado: (2002) -
Characterization of soluble E-cadherin as a disease marker in gastric cancer patients.
por: Gofuku, J., et al.
Publicado: (1998) -
Soluble E-cadherin fragments increased in circulation of cancer patients.
por: Katayama, M., et al.
Publicado: (1994) -
E-Cadherin: An Enigma in Pancreatic Diseases
por: Garrido, Vanessa T., et al.
Publicado: (2019) -
Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal Cancers
por: Repetto, Ombretta, et al.
Publicado: (2014)